Cargando…
Correction to: Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression
Autores principales: | Antinori, Andrea, Cossu, Maria V., Menzaghi, Barbara, Sterrantino, Gaetana, Squillace, Nicola, Di Cristo, Valentina, Cattelan, Annamaria, Focà, Emanuele, Castagna, Antonella, Orofino, Giancarlo, Valenti, Daniela, D’Ettore, Gabriella, Aprea, Lucia, Ferrara, Sergio, Locatelli, Maria E., Madeddu, Giordano, Pontali, Emanuele, Scerbo, Paolo, Rossetti, Barbara, Uglietti, Alessia, Termini, Roberta, Rucci, Francesco, Gori, Andrea, Mancusi, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340669/ https://www.ncbi.nlm.nih.gov/pubmed/32468416 http://dx.doi.org/10.1007/s40271-020-00425-8 |
Ejemplares similares
-
Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression
por: Antinori, Andrea, et al.
Publicado: (2020) -
Effectiveness of Switching to Darunavir/Cobicistat in Virologically Suppressed HIV-Positive Patients Receiving Ritonavir-Boosted Protease Inhibitor–Based Regimen: The “STORE” Study
por: Gori, Andrea, et al.
Publicado: (2020) -
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: results from a large multicentre observational prospective cohort (SCOLTA)
por: Taramasso, Lucia, et al.
Publicado: (2019) -
Darunavir–cobicistat–emtricitabine–tenofovir alafenamide: safety and efficacy of a protease inhibitor in the modern era
por: Squillace, Nicola, et al.
Publicado: (2018) -
Effectiveness and durability of darunavir/ritonavir (DRV/r) in DRV/r-experienced HIV-1-infected patients in routine clinical practice
por: Antinori, Andrea, et al.
Publicado: (2014)